Skip to content
Abierto

Award notice, first published as presolicitation

Pregabalin Capsules

36E79725R0055

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

Awarded

Sciegen Pharmaceuticals Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the solicitation of September 30, 2025.

Amendment to Extend Due Date and Time for Offers This amendment is issued to extend the due date and time for receipt of offers submitted in response to solicitation 36E79725R0055 for Pregabalin Capsules from 10/02/2025 to 10/16/2025 at 2:30PM Central Time. All other solicitation terms and conditions remain unchanged. Offerors shall include a completed and signed copy of the amendment with their proposal.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
WH8BR7NRXLC5
CAGE
8NLP1
Vendor location
Hauppauge, NY
Contract
36E79726D0006
Obligated
$0.00, potential $14,500,887
Actions
2 between December 1, 2025 and August 27, 2026
Competition
Full and Open Competition, 4 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Pregabalin Capsules with Sciegen Pharmaceuticals. Ordering Period Is March 2, 2026 to March 1, 2027, with Four ONE-YEAR Options.
Match
award number 36E79726D0006 equals the contract number; same awarding office 36E797 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 14, 2025

    Presolicitation

    Due October 2, 2025 at 3:30 PM EDT. SAM.gov, notice 7f6119f3d6dc41bdaa94d6b18cc0d3ac

  2. September 15, 2025

    Solicitation, originally presolicitation

    Due September 15, 2025 at 3:30 PM EDT. SAM.gov, notice b46086871bf24bccb17d295365efb624

  3. September 30, 2025

    Solicitation

    Due October 16, 2025 at 3:30 PM EDT. SAM.gov, notice 4c5f176760c34437a9e0afa0bf40a918

  4. February 11, 2026

    Award notice

    Awarded to Sciegen Pharmaceuticals Inc. Hauppauge 11788 for $14,500,887. SAM.gov, notice 4041bcbb37db4ac3bebad05067c4b487

Points of contact